Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): Stock That Needs Special Handling
Currently, there are 244.92M common shares owned by the public and among those 239.55M shares have been available to trade. The company’s stock has a 5-day price change of -18.12% and 28.41% over the past three months. LXRX shares are trading 10.78% year to date (YTD), with the 12-month market performance down to -29.67% lower. […]
Lexicon Pharmaceuticals Inc (LXRX): Not A Time To Panic Nor Freeze
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $2.04, with 4.38 million shares of worth about $8.94 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 100.00% during that period and on April 3, 2024 the price saw a […]
Reviewing The Case For Lexicon Pharmaceuticals Inc (LXRX) Going Higher
Currently, there are 244.92M common shares owned by the public and among those 238.24M shares have been available to trade. The company’s stock has a 5-day price change of -18.85% and 51.15% over the past three months. LXRX shares are trading 29.41% year to date (YTD), with the 12-month market performance down to -14.66% lower. […]
Assessing Whether Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) Is Over- Or Undervalued
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Thursday at a closing price of $2.41, with 2.39 million shares of worth about $5.76 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 107.76% during that period and on March 21, 2024 the price saw a […]
Why Should You Put Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) On Your Portfolio?
Currently, there are 244.93M common shares owned by the public and among those 238.24M shares have been available to trade. The company’s stock has a 5-day price change of 12.00% and 101.60% over the past three months. LXRX shares are trading 64.71% year to date (YTD), with the 12-month market performance up to 14.03% higher. […]
Handle With Care: Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)
Currently, there are 244.93M common shares owned by the public and among those 238.68M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]
Growing Through Challenges? – Lexicon Pharmaceuticals Inc (LXRX)
Currently, there are 244.93M common shares owned by the public and among those 238.68M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): The Best-Of-Breed For Investing?
Currently, there are 244.93M common shares owned by the public and among those 238.79M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): Analyst View Points To Future Growth
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $2.15, with 4.03 million shares of worth about $8.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.13% during that period and on Wednesday February 7 the price saw a […]
Are Analysts Expecting A Better 2020 For Lexicon Pharmaceuticals Inc (LXRX)?
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $1.87, with 4.94 million shares of worth about $9.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.61% during that period and on Wednesday, January 31 the price saw a […]
